Log in

Relevant bibliographies by topics / Structure-activity relationship (Pharmacology) / Journal articles

To see the other types of publications on this topic, follow the link: Structure-activity relationship (Pharmacology).

Journal articles on the topic 'Structure-activity relationship (Pharmacology)'

Author: Grafiati

Published: 4 June 2021

Last updated: 28 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Structure-activity relationship (Pharmacology).'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Sukamoto, Takayuki, and Tadayuki Saito. "The structure-activity relationship of anti-histamines." Japanese Journal of Pharmacology 71 (1996): 18. http://dx.doi.org/10.1016/s0021-5198(19)36336-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Topal, Fevzi, Meryem Nar, Hulya Gocer, et al. "Antioxidant activity of taxifolin: an activity–structure relationship." Journal of Enzyme Inhibition and Medicinal Chemistry 31, no. 4 (2015): 674–83. http://dx.doi.org/10.3109/14756366.2015.1057723.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Wu, Tao, Osafo Raymond Kwaku, Hai-Zhou Li, Chong-Ren Yang, Long-Jiao Ge, and Min Xu. "Sense Ginsenosides From Ginsengs: Structure-Activity Relationship in Autophagy." Natural Product Communications 14, no. 6 (2019): 1934578X1985822. http://dx.doi.org/10.1177/1934578x19858223.

Full text

Abstract:

The term ginseng refers to the dried roots of several plants belonging to the genus Panax of the Araliaceae family. The 3 major commercial ginsengs are Panax notoginseng (Burk.) F.H. Chen (Notoginseng), P. ginseng C.A. Meyer (Ginseng), and P. quinquefolius L. (American ginseng), which have been used as herbal medicines. Over 18,000 papers on ginsengs have been published on the basis of their structural diversity and biological activities. Many reviews have summarized the phytochemistry, pharmacology, and clinical use of ginsengs, but the structure-activity relationship (SAR) of ginsenosides fr

APA, Harvard, Vancouver, ISO, and other styles

4

Shih-Fong, Chen, Lisa M. Papp, Robert J. Ardecky, et al. "Structure-activity relationship of quinoline carboxylic acids." Biochemical Pharmacology 40, no. 4 (1990): 709–14. http://dx.doi.org/10.1016/0006-2952(90)90305-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Wawer, Mathias J., David E. Jaramillo, Vlado Dančík, et al. "Automated Structure–Activity Relationship Mining." Journal of Biomolecular Screening 19, no. 5 (2014): 738–48. http://dx.doi.org/10.1177/1087057114530783.

Full text

Abstract:

Understanding the structure–activity relationships (SARs) of small molecules is important for developing probes and novel therapeutic agents in chemical biology and drug discovery. Increasingly, multiplexed small-molecule profiling assays allow simultaneous measurement of many biological response parameters for the same compound (e.g., expression levels for many genes or binding constants against many proteins). Although such methods promise to capture SARs with high granularity, few computational methods are available to support SAR analyses of high-dimensional compound activity profiles. Man

APA, Harvard, Vancouver, ISO, and other styles

6

TAKAGI, Kenzo, Takaaki HASEGAWA, Takafumi KUZUYA, et al. "Structure-Activity Relationship in N3-Alkyl-Xanthine Derivatives." Japanese Journal of Pharmacology 46, no. 4 (1988): 373–78. http://dx.doi.org/10.1016/s0021-5198(19)43290-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

TAKAGI, Kenzo, Takaaki HASEGAWA, Takafumi KUZUYA, et al. "Structure-activity relationship in N3-alkyl-xanthine derivatives." Japanese Journal of Pharmacology 46, no. 4 (1988): 373–78. http://dx.doi.org/10.1254/jjp.46.373.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Betelina, I. B., L. A. Tyurina, S. A. Kirlan, et al. "Structure-biological activity relationship in prostaglandin analogs." Pharmaceutical Chemistry Journal 40, no. 8 (2006): 424–29. http://dx.doi.org/10.1007/s11094-006-0145-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

MIURA, Toshihiro, Yumi NISHIYAMA, Momoyo ICHIMARU, Masataka MORIYASU, and Atsushi KATO. "HYPOGLYCEMIC ACTIVITY AND STRUCTURE-ACTIVITY RELATIONSHIP OF IRIDOIDAL GLYCOSIDES." Biological & Pharmaceutical Bulletin 19, no. 1 (1996): 160–61. http://dx.doi.org/10.1248/bpb.19.160.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Dvoryantseva, G. G., S. V. Lindeman, Yu T. Struchkov, et al. "Structure-activity relationship in ?-carboline derivatives. Molecular structure of Inkasan." Pharmaceutical Chemistry Journal 19, no. 12 (1985): 822–31. http://dx.doi.org/10.1007/bf01148378.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Oganesyan, �. T., A. S. Saraf, A. V. Simonyan, and I. N. Shiryaev. "Structure-activity relationship in flavonoids. 9. Antiallergic activity of chalcones." Pharmaceutical Chemistry Journal 25, no. 8 (1991): 526–30. http://dx.doi.org/10.1007/bf00777414.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Senff-Ribeiro, Andrea, Aurea Echevarria, Edson F. Silva, Silvio S. Veiga, and Maria B. M. Oliveira. "Antimelanoma activity of 1,3,4-thiadiazolium mesoionics: a structure–activity relationship study." Anti-Cancer Drugs 15, no. 3 (2004): 269–75. http://dx.doi.org/10.1097/00001813-200403000-00012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Liu, Xin-nan, Hui-min Li, Shu-ping Wang, Jing-ze Zhang, and Dai-lin Liu. "Sesquiterpene lactones of Aucklandia lappa: Pharmacology, pharmacokinetics, toxicity, and structure–activity relationship." Chinese Herbal Medicines 13, no. 2 (2021): 167–76. http://dx.doi.org/10.1016/j.chmed.2020.11.005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Bonano, J. S., M. L. Banks, R. Kolanos, et al. "Quantitative structure-activity relationship analysis of the pharmacology ofpara-substituted methcathinone analogues." British Journal of Pharmacology 172, no. 10 (2015): 2433–44. http://dx.doi.org/10.1111/bph.13030.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Farhadi, Faegheh, Bahman Khameneh, Mehrdad Iranshahi, and Milad Iranshahy. "Antibacterial activity of flavonoids and their structure-activity relationship: An update review." Phytotherapy Research 33, no. 1 (2018): 13–40. http://dx.doi.org/10.1002/ptr.6208.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Shaw, Simon. "The Structure Activity Relationship of Discodermolide Analogues." Mini-Reviews in Medicinal Chemistry 8, no. 3 (2008): 276–84. http://dx.doi.org/10.2174/138955708783744137.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Nelson, Sharon H., and Odd S. Steinsland. "Dopamine receptors: Structure-activity relationship of d-tubocurarine analogues." European Journal of Pharmacology 108, no. 2 (1985): 209–12. http://dx.doi.org/10.1016/0014-2999(85)90729-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Bertrand, G., J. Chapal, P. Petit, and M. M. Loubatières-Mariani. "P2 purinoceptor agonists and insulin secretion: structure-activity relationship." European Journal of Pharmacology 183, no. 2 (1990): 579. http://dx.doi.org/10.1016/0014-2999(90)93494-b.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Gupta, Satya. "Quantitative Structure-Activity Relationship Studies on Cholecystokinin Antagonists." Current Pharmaceutical Design 8, no. 2 (2002): 111–24. http://dx.doi.org/10.2174/1381612023396500.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Huang, X. F., J. Y. Xue, A. Q. Jiang, and H. L. Zhu. "Capsaicin and Its Analogues: Structure-Activity Relationship Study." Current Medicinal Chemistry 20, no. 21 (2013): 2661–72. http://dx.doi.org/10.2174/0929867311320210004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Brown, Andrew J., Irene Castellano-Pellicena, Carl P. Haslam, Paula L. Nichols, and Simon J. Dowell. "Structure-Activity Relationship of the GPR55 Antagonist, CID16020046." Pharmacology 102, no. 5-6 (2018): 324–31. http://dx.doi.org/10.1159/000493490.

Full text

Abstract:

Background/Aims: CID16020046 blocks the effect of the lipid lysophosphatidylinositol (LPI) at its receptor, GPR55. CID16020046 and another antagonist, ML193, have been used to investigate GPR55-mediated effects of LPI on cells, tissues, and in vivo. Here we describe the structure-activity relationship of CID16020046. Methods: Yeast or human cells were engineered to express GPR55 or control receptors. Cells were pretreated with a test agent before agonist challenge. Functional responses were quantified by yeast gene-reporter or calcium imaging. Results: Three substituents around the central pyr

APA, Harvard, Vancouver, ISO, and other styles

22

Kamernitskii, A. V., and I. S. Levina. "Pregna-D1-pentaranes. II. Structure-activity relationship (review)." Pharmaceutical Chemistry Journal 25, no. 10 (1991): 669–87. http://dx.doi.org/10.1007/bf00768975.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Takenaga, Norihiro, Mikio Ishii, Toshio Kamei, and Toshio Yasumori. "Structure-Activity Relationship inO-Glucuronidation of Indolocarbazole Analogs." Drug Metabolism and Disposition 30, no. 5 (2002): 494–97. http://dx.doi.org/10.1124/dmd.30.5.494.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Isaev, S. D., M. I. Novikova, I. G. Semenova, et al. "Adamantylureas. Relationship between structure and virus inhibitory activity." Pharmaceutical Chemistry Journal 23, no. 9 (1989): 757–60. http://dx.doi.org/10.1007/bf00764443.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Wang, Xuejian, Fanbo Jing, Huawei Zhu, Hao Fang, Jian Zhang, and Wenfang Xu. "Activity screening and structure-activity relationship of the hit compounds targeting APN/CD13." Fundamental & Clinical Pharmacology 25, no. 2 (2011): 217–28. http://dx.doi.org/10.1111/j.1472-8206.2010.00844.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Oganesyan, �. T., I. S. Gushchin, S. R. Pershkov, and A. S. Saraf. "Relationship between structure and activity of flavone derivatives possessing antiallergic activity." Pharmaceutical Chemistry Journal 23, no. 10 (1989): 852–56. http://dx.doi.org/10.1007/bf00764819.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

De Sarro, A., G. B. De Sarro, C. Ascioti та G. Nisticó. "Epileptogenic activity of some β-lactam derivatives: Structure-activity relationship". Neuropharmacology 28, № 4 (1989): 359–65. http://dx.doi.org/10.1016/0028-3908(89)90030-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Tasdemir, Deniz, Marcel Kaiser, Reto Brun, et al. "Antitrypanosomal and Antileishmanial Activities of Flavonoids and Their Analogues: In Vitro, In Vivo, Structure-Activity Relationship, and Quantitative Structure-Activity Relationship Studies." Antimicrobial Agents and Chemotherapy 50, no. 4 (2006): 1352–64. http://dx.doi.org/10.1128/aac.50.4.1352-1364.2006.

Full text

Abstract:

ABSTRACT Trypanosomiasis and leishmaniasis are important parasitic diseases affecting millions of people in Africa, Asia, and South America. In a previous study, we identified several flavonoid glycosides as antiprotozoal principles from a Turkish plant. Here we surveyed a large set of flavonoid aglycones and glycosides, as well as a panel of other related compounds of phenolic and phenylpropanoid nature, for their in vitro activities against Trypanosoma brucei rhodesiense, Trypanosoma cruzi, and Leishmania donovani. The cytotoxicities of more than 100 compounds for mammalian L6 cells were als

APA, Harvard, Vancouver, ISO, and other styles

29

Wang, R. B., C. L. Kuo, L. L. Lien, and E. J. Lien. "Structure-activity relationship: analyses of p-glycoprotein substrates and inhibitors." Journal of Clinical Pharmacy and Therapeutics 28, no. 3 (2003): 203–28. http://dx.doi.org/10.1046/j.1365-2710.2003.00487.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

C. S., Ananda Kumar, S. B. Benaka Prasad, K. Vinaya, et al. "Synthesis and antiproliferative activity of substituted diazaspiro hydantoins: a structure–activity relationship study." Investigational New Drugs 27, no. 2 (2008): 131–39. http://dx.doi.org/10.1007/s10637-008-9150-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Liu, Si-Yu, and Diane M. Sylvester. "Antiplatelet structure-activity relationship of tetramethylpyrazine." Life Sciences 55, no. 17 (1994): 1317–26. http://dx.doi.org/10.1016/0024-3205(94)00764-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Ifrah, Dan, Xavier Doisy, Trine S. Ryge, and Paul R. Hansen. "Structure-activity relationship study of anoplin." Journal of Peptide Science 11, no. 2 (2005): 113–21. http://dx.doi.org/10.1002/psc.598.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Heijnen, Chantal G. M., Guido R. M. M. Haenen, Jef A. J. M. Vekemans, and Aalt Bast. "Peroxynitrite scavenging of flavonoids: structure activity relationship." Environmental Toxicology and Pharmacology 10, no. 4 (2001): 199–206. http://dx.doi.org/10.1016/s1382-6689(01)00083-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Melis, M. R., A. Argiolas, R. Stancampino, and G. L. Gessa. "Oxytocin-induced penile erection and yawning: Structure-activity relationship studies." Pharmacological Research Communications 20, no. 12 (1988): 1117–18. http://dx.doi.org/10.1016/s0031-6989(88)80754-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Choi, Jae Sue, Hae Young Chung, Sam Sik Kang, et al. "The structure-activity relationship of flavonoids as scavengers of peroxynitrite." Phytotherapy Research 16, no. 3 (2002): 232–35. http://dx.doi.org/10.1002/ptr.828.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Neves, Ana R., Marta Correia-da-Silva, Emília Sousa, and Madalena Pinto. "Structure–activity relationship studies for multitarget antithrombotic drugs." Future Medicinal Chemistry 8, no. 18 (2016): 2305–55. http://dx.doi.org/10.4155/fmc-2015-0020.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

M. Lopez-Lazaro. "Flavonoids as Anticancer Agents: Structure-Activity Relationship Study." Current Medicinal Chemistry-Anti-Cancer Agents 2, no. 6 (2002): 691–714. http://dx.doi.org/10.2174/1568011023353714.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Esplin, B., Y. Théorêt, E. Seward, and R. Capek. "Epileptogenic action of penicillin derivatives: structure-activity relationship." Neuropharmacology 24, no. 6 (1985): 571–75. http://dx.doi.org/10.1016/0028-3908(85)90066-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Niculescu-Duvaz, Dan, James Heyes, and Caroline Springer. "Structure-Activity Relationship in Cationic Lipid Mediated Gene Transfection." Current Medicinal Chemistry 10, no. 14 (2003): 1233–61. http://dx.doi.org/10.2174/0929867033457476.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Batool, Sidra, Nighat Noureen, and Mohammad Amjad Kamal. "Structure Activity Relationship of Venom Toxins Targeting Potassium Channels." Current Drug Metabolism 19, no. 8 (2018): 714–20. http://dx.doi.org/10.2174/1389200219666171227205009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Behl, Christian, Thomas Skutella, Frank Lezoualc’H, et al. "Neuroprotection against Oxidative Stress by Estrogens: Structure-Activity Relationship." Molecular Pharmacology 51, no. 4 (1997): 535–41. http://dx.doi.org/10.1124/mol.51.4.535.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Klopman, Gilles, Leming M. Shi, and Avner Ramu. "Quantitative Structure-Activity Relationship of Multidrug Resistance Reversal Agents." Molecular Pharmacology 52, no. 2 (1997): 323–34. http://dx.doi.org/10.1124/mol.52.2.323.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Moosmann, Bernd, and Christian Behl. "Secretory Peptide Hormones Are Biochemical Antioxidants: Structure-Activity Relationship." Molecular Pharmacology 61, no. 2 (2002): 260–68. http://dx.doi.org/10.1124/mol.61.2.260.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Avetisyan, S. A., N. S. Nesunts, N. S. Buyukyan, et al. "Relationship between chemical structure and anticonvulsant activity in succinimides." Pharmaceutical Chemistry Journal 22, no. 4 (1988): 309–13. http://dx.doi.org/10.1007/bf00768251.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Romanova, N. N. "?-Lactams: Relationship of structure and stereochemistry to biological activity." Pharmaceutical Chemistry Journal 24, no. 1 (1990): 20–25. http://dx.doi.org/10.1007/bf00769380.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Passet, B. V., A. A. Golubyatnikova, N. V. Enina, S. V. Nekrasov, and E. T. Mordvinova. "Relationship of structure to antimicrobial activity in anionic surfactants." Pharmaceutical Chemistry Journal 19, no. 11 (1985): 797–802. http://dx.doi.org/10.1007/bf00766636.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Kabankin, A. S., L. A. Radkevich, L. I. Gabrielyan, V. P. Zhestkov, N. V. Ostapchuk, and N. E. Pyn'ko. "Relationship Between Structure and Hepatoprotector Activity of Indole Derivatives." Pharmaceutical Chemistry Journal 39, no. 4 (2005): 191–96. http://dx.doi.org/10.1007/s11094-005-0115-y.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Singh, Harbinder, Nihar Kinarivala, and Sahil Sharma. "Multi-Targeting Anticancer Agents: Rational Approaches, Synthetic Routes and Structure Activity Relationship." Anti-Cancer Agents in Medicinal Chemistry 19, no. 7 (2019): 842–74. http://dx.doi.org/10.2174/1871520619666190118120708.

Full text

Abstract:

We live in a world with complex diseases such as cancer which cannot be cured with one-compound one-target based therapeutic paradigm. This could be due to the involvement of multiple pathogenic mechanisms. One-compound-various-targets stratagem has become a prevailing research topic in anti-cancer drug discovery. The simultaneous interruption of two or more targets has improved the therapeutic efficacy as compared to the specific targeted based therapy. In this review, six types of dual targeting agents along with some interesting strategies used for their design and synthesis are discussed.

APA, Harvard, Vancouver, ISO, and other styles

49

Bigaud, M., B. Hauss, C. Schalk, MF Jauch, and H. D'Orchymont. "Structure activity relationship of phosphoramidon derivatives forin vivoendothelin-converting-enzyme inhibition." Fundamental & Clinical Pharmacology 8, no. 2 (1994): 155–61. http://dx.doi.org/10.1111/j.1472-8206.1994.tb00792.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Nagano, H., K. Ijichi, M. Fujiwara, et al. "Structure - activity relationship of non-nucleoside RT inhibitor, thiadizaole derivatives." Antiviral Research 30, no. 1 (1996): A30. http://dx.doi.org/10.1016/0166-3542(96)80265-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!